» Articles » PMID: 33571815

Endocannabinoid System: Role in Blood Cell Development, Neuroimmune Interactions and Associated Disorders

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2021 Feb 11
PMID 33571815
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The endocannabinoid system (ECS) is a complex physiological network involved in creating homeostasis and maintaining human health. Studies of the last 40 years have shown that endocannabinoids (ECs), a group of bioactive lipids, together with their set of receptors, function as one of the most important physiologic systems in human body. ECs and cannabinoid receptors (CBRs) are found throughout the body: in the brain tissues, immune cells, and in the peripheral organs and tissues as well. In recent years, ECs have emerged as key modulators of affect, neurotransmitter release, immune function, and several other physiological functions. This modulatory homoeostatic system operates in the regulation of brain activity and states of physical health and disease. In several research studies and patents the ECS has been recognised with neuro-protective properties thus it might be a target in neurodegenerative diseases. Most immune cells express these bioactive lipids and their receptors, recent data also highlight the immunomodulatory effects of endocannabinoids. Interplay of immune and nervous system has been recognized in past, recent studies suggest that ECS function as a bridge between neuronal and immune system. In several ongoing clinical trial studies, the ECS has also been placed in the anti-cancer drugs spotlight. This review summarizes the literature of cannabinoid ligands and their biosynthesis, cannabinoid receptors and their distribution, and the signaling pathways initiated by the binding of cannabinoid ligands to cannabinoid receptors. Further, this review highlights the functional role of cannabinoids and ECS in blood cell development, neuroimmune interactions and associated disorders. Moreover, we highlight the current state of knowledge of cannabinoid ligands as the mediators of neuroimmune interactions, which can be therapeutically effective for neuro-immune disorders and several diseases associated with neuroinflammation.

Citing Articles

Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review.

Alfei S, Schito G, Schito A Pharmaceutics. 2023; 15(7).

PMID: 37514074 PMC: 10384972. DOI: 10.3390/pharmaceutics15071889.


Endocannabinoid System: Chemical Characteristics and Biological Activity.

Rezende B, Nogueira Alencar A, Freitas de Bem G, Fontes-Dantas F, Montes G Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37017445 PMC: 9966761. DOI: 10.3390/ph16020148.


Endocannabinoid levels in peripheral blood mononuclear cells of multiple sclerosis patients treated with dimethyl fumarate.

Sanchez-Sanz A, Posada-Ayala M, Sabin-Munoz J, Fernandez-Miranda I, Aladro-Benito Y, Alvarez-Lafuente R Sci Rep. 2022; 12(1):20300.

PMID: 36434122 PMC: 9700785. DOI: 10.1038/s41598-022-21807-y.


Impact of the Cannabinoid System in Alzheimer's Disease.

Li S, Huang Y, Yu L, Ji X, Wu J Curr Neuropharmacol. 2022; 21(3):715-726.

PMID: 35105293 PMC: 10207907. DOI: 10.2174/1570159X20666220201091006.


Citrobacter rodentium infection at the gut-brain axis interface.

Martins F, Cuesta S Curr Opin Microbiol. 2021; 63:59-65.

PMID: 34217915 PMC: 8463425. DOI: 10.1016/j.mib.2021.06.003.